CA1314222C - Pharmaceutical composition for use against hypertension and congestive heart failure - Google Patents

Pharmaceutical composition for use against hypertension and congestive heart failure

Info

Publication number
CA1314222C
CA1314222C CA000551575A CA551575A CA1314222C CA 1314222 C CA1314222 C CA 1314222C CA 000551575 A CA000551575 A CA 000551575A CA 551575 A CA551575 A CA 551575A CA 1314222 C CA1314222 C CA 1314222C
Authority
CA
Canada
Prior art keywords
alkyl
carbon atoms
hydroxy
component
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000551575A
Other languages
English (en)
French (fr)
Inventor
Helene Siegl
Robert Paul Hof
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of CA1314222C publication Critical patent/CA1314222C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA000551575A 1986-11-03 1987-10-30 Pharmaceutical composition for use against hypertension and congestive heart failure Expired - Fee Related CA1314222C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB8626217 1986-11-03
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions
GB8713349 1987-06-08

Publications (1)

Publication Number Publication Date
CA1314222C true CA1314222C (en) 1993-03-09

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000551575A Expired - Fee Related CA1314222C (en) 1986-11-03 1987-10-30 Pharmaceutical composition for use against hypertension and congestive heart failure

Country Status (25)

Country Link
KR (1) KR960005145B1 (de)
AT (1) AT397343B (de)
AU (1) AU615883B2 (de)
BE (1) BE1002063A4 (de)
CA (1) CA1314222C (de)
CH (1) CH677189A5 (de)
DE (1) DE3736505A1 (de)
DK (1) DK574087A (de)
ES (1) ES2010524A6 (de)
FI (1) FI874823A (de)
FR (1) FR2605885B1 (de)
GR (1) GR871680B (de)
HK (1) HK138893A (de)
HU (1) HU199681B (de)
IE (1) IE60496B1 (de)
IL (1) IL84343A (de)
IT (1) IT1212037B (de)
LU (1) LU87034A1 (de)
MY (1) MY102124A (de)
NL (1) NL8702502A (de)
NO (1) NO874539L (de)
NZ (1) NZ222401A (de)
PH (1) PH23249A (de)
PT (1) PT86062B (de)
SE (1) SE8704272L (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2733911B1 (fr) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd Composition pharmaceutique pour maladies renales ou cardio-vasculaires

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
HUT47847A (en) 1989-04-28
GR871680B (en) 1988-05-02
FR2605885A1 (fr) 1988-05-06
NO874539L (no) 1988-05-04
FI874823A (fi) 1988-05-04
HU199681B (en) 1990-03-28
AU8057687A (en) 1988-05-05
PT86062B (pt) 1990-11-07
IL84343A0 (en) 1990-02-09
ES2010524A6 (es) 1989-11-16
IL84343A (en) 1993-07-08
KR960005145B1 (ko) 1996-04-22
CH677189A5 (de) 1991-04-30
DK574087A (da) 1988-05-04
NZ222401A (en) 1991-04-26
ATA286987A (de) 1993-08-15
IE872951L (en) 1988-05-03
PH23249A (en) 1989-06-16
SE8704272D0 (sv) 1987-11-02
MY102124A (en) 1992-03-31
PT86062A (en) 1987-12-01
AU615883B2 (en) 1991-10-17
LU87034A1 (fr) 1988-05-03
IE60496B1 (en) 1994-07-27
IT1212037B (it) 1989-11-08
SE8704272L (sv) 1988-05-04
FR2605885B1 (fr) 1993-09-10
NO874539D0 (no) 1987-11-02
DK574087D0 (da) 1987-11-02
FI874823A0 (fi) 1987-11-02
BE1002063A4 (fr) 1990-06-12
IT8748553A0 (it) 1987-10-30
HK138893A (en) 1993-12-24
DE3736505A1 (de) 1988-05-05
NL8702502A (nl) 1988-06-01
AT397343B (de) 1994-03-25
KR880006197A (ko) 1988-07-22

Similar Documents

Publication Publication Date Title
RU2041211C1 (ru) Конденсированные 5-членные гетероциклы или их соли, проявляющие активность по торможению агрегации
US4466972A (en) Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
SU1349700A3 (ru) Способ получени (2-оксо-1,2,3,5-тетрагидроимидазо-/2,1- @ /хиназолинил)оксиалкиламидов,их оптических изомеров или фармакологически приемлемых солей с кислотами
EP0960106B1 (de) 1-phenyl-4-benzylpiperazine: spezifische liganden für den dopamin rezeptor (d4)
US4703038A (en) Combination of dihydropyridines with angiotensin converting enzymes-inhibitors
EP0119050B1 (de) Anti-ischaemische und antihypertensive Dihydropyridin-Mittel
JPH07291964A (ja) 新規ベンズイミダゾ−ルのピペリジン誘導体
CA2003289C (en) Use of trifluoromethylphenyl-tetrahydropyridines for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders
JP2002537258A5 (de)
CA1131228A (en) Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them
CA1314222C (en) Pharmaceutical composition for use against hypertension and congestive heart failure
JPH0334926A (ja) 抗不安薬
HU217443B (hu) Heterociklusos imino-bisz-metilén-biszfoszfonsav-származékok, eljárás előállításukra, és ezeket hatóanyagként tartalmazó gyógyszerkészítmények
US4859665A (en) Antihypertensive combination products containing a dihydropyridine and a pyridazodiazepine
US5037821A (en) Method for inhibiting loss of cognitive functions employing a calcium channel blocker alone or in combination with an ACE inhibitor
CA1177754A (en) Pharmaceutical compositions, effective against coronary heart disease and hypertension
US5114919A (en) Adjuncts in cancer chemotherapy
CA1250291A (en) Psychogeriatric 1-(2-pyrimidinyl)-piperazinyl derivatives of 1-pyrrolidin-2-ones
GB2198641A (en) Pharmaceutical cardiac compositions containing calcium antagonists
USH734H (en) Method for inhibiting onset of or treating migraine headaches employing an ACE inhibitor
EP0381074A2 (de) Verfahren zur Diäterleichterung unter Verwendung eines ACE-Inhibitors
CA1255596A (en) Pharmaceutical compositions containing dihydropyridine
US5182387A (en) Bis-dibenzoazepine compounds
EP0107293A2 (de) Dihydropyridine
IE922412A1 (en) 1,4-dihydropyridines with PAF-antagonistic activity

Legal Events

Date Code Title Description
MKLA Lapsed